Literature DB >> 16243243

Sclerotherapy of benign oral vascular lesion with ethanolamine oleate: an open clinical trial with 30 lesions.

Aline Cristina Batista Rodrigues Johann1, Maria Cássia Ferreira Aguiar, Maria Auxiliadora Vieira do Carmo, Ricardo Santiago Gomez, Wagner Henriques Castro, Ricardo Alves Mesquita.   

Abstract

OBJECTIVE: The objective of this study was to report and discuss the results from treatment of benign oral vascular lesions with ethanolamine oleate. STUDY
DESIGN: Twenty-seven patients with 30 examples of oral vascular malformation, hemangioma, or varix were treated with intralesional injections of 1.25% or 2.5% ethanolamine oleate at an interval of 15 days between each application. The lesions were divided into 2 categories: (1) lesions of 20 mm or less and (2) those greater than 20 mm. Subsequently, the Mann-Whitney test was used a means of statistical analysis.
RESULTS: Although the number of injections varied from patient to patient, all lesions responded to the treatment, showing total clinical regression. Lesions of 20 mm or less needed a lesser number of applications than those greater than 20 mm (P < .05).
CONCLUSIONS: Ethanolamine oleate is a 100% effective sclerosant agent for treatment of benign oral vascular lesions. In this study, no difference was found between the 2 concentrations applied.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16243243     DOI: 10.1016/j.tripleo.2004.12.021

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  17 in total

1.  A Step-by-Step Practical Approach to Imaging Diagnosis and Interventional Radiologic Therapy in Vascular Malformations.

Authors:  Gerald M Legiehn; Manraj K S Heran
Journal:  Semin Intervent Radiol       Date:  2010-06       Impact factor: 1.513

2.  Nd:YAG laser photocoagulation of benign oral vascular lesions: a case series.

Authors:  Rui Medeiros; Igor Henrique Silva; Alessandra Tavares Carvalho; Jair Carneiro Leão; Luiz Alcino Gueiros
Journal:  Lasers Med Sci       Date:  2015-05-12       Impact factor: 3.161

3.  Cavernous hemangioma of tongue: management of two cases.

Authors:  Pranitha V; Niharika Puppala; Sudhanwa N Deshmukh; Jagadesh B; Anuradha S
Journal:  J Clin Diagn Res       Date:  2014-10-20

4.  Sclerotherapy using 1% sodium tetradecyl sulfate to treat a vascular malformation: a report of two cases.

Authors:  Hong-Gi Min; Su-Gwan Kim; Ji-Su Oh; Jae-Seek You
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2015-12-17

5.  Oral capillary hemangioma: a clinical protocol of diagnosis and treatment in adults.

Authors:  Walessa Brasil da Silva; André Luis Ribeiro Ribeiro; Sílvio Augusto Fernandes de Menezes; João de Jesus Viana Pinheiro; Sérgio de Melo Alves-Junior
Journal:  Oral Maxillofac Surg       Date:  2013-11-22

6.  Life-threatening pharyngeal edema after sclerotherapy of oral venous malformations in a patient with blue rubber bleb nevus syndrome.

Authors:  Scott F Lindsey; Brandon Reiders; Hilit F Mechaber
Journal:  J Dermatol Case Rep       Date:  2013-09-30

7.  Management of palatal vascular malformation using absolute ethanol sclerotherapy.

Authors:  Ibrahim El-Hakim; Ahmed Alyamani
Journal:  Clin Pract       Date:  2011-11-02

8.  Gingival bleeding of a high-flow mandibular arteriovenous malformation in a child with 8-year follow-up.

Authors:  Elvira Ferrés-Amat; Jordi Prats-Armengol; Isabel Maura-Solivellas; Eduard Ferrés-Amat; Javier Mareque-Bueno; Eduard Ferrés-Padró
Journal:  Case Rep Pediatr       Date:  2015-03-17

9.  Minimal Invasive Surgical Management of Familial Arteriovenous Malformation.

Authors:  Mokhtar Mamdouh Abdel-Latif; Shankargouda Patil
Journal:  Case Rep Dent       Date:  2021-06-09

10.  Intramuscular hemangioma in lip treated with sclerotherapy and surgery.

Authors:  Vanessa A Silva; Nádia L Lima; Ana Terezinha M Mesquita; Esmeralda Maria da Silveira; Flaviana D Verli; João Luiz de Miranda; Cássio Roberto R Santos; Sandra A Marinho
Journal:  Case Rep Dent       Date:  2011-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.